<DOC>
	<DOCNO>NCT01921478</DOCNO>
	<brief_summary>This retrospective , multi-centre , observational study assess daily practice pattern outcomes management rheumatoid arthritis patient treat RoActemra/Actemra ( tocilizumab ) . No actual patient enrol study ; data collect medical record .</brief_summary>
	<brief_title>A Retrospective , Observational Study RoActemra/Actemra ( Tocilizumab ) Clinical Practice Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Adult patient , &gt; =18 year age Diagnosed rheumatoid arthritis moderate severe disease activity define DAS28 &gt; =5.1 Inadequate responder least 2 nonbiological DMARDs Absence document erosion start RoActemra/Actemra treatment Received RoActemra/Actemra treatment least 6 month Availability data least RoActemra/Actemra treatment initiation visit 6 month visit Contraindications treatment RoActemra/Actemra</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>